In support of this, expression levels of IFI16 and anti-IFI16 autoantibodies were dramatically increased in SLE patients, indicating that IFI16 has similar features to p202 (Mondini et al., 2006). This evidence concerns the gene TP53BP1 and systemic lupus erythematosus.